Concepedia
Statistics
Publications
8
Citations
445
H-Index
Active since
1998
Affiliations
Takeda (United States)(Current)
Deerfield (United States)
Virginia Commonwealth University Medical Center
University of Washington
Stony Brook University
Melvin Munsaka is an author at Takeda (United States) specializing in pharmacology, pharmacy, and clinical pharmacology.
Publications per year
1998–2018
Cardiovascular safety of the dipetidyl peptidase‐4 inhibitor alogliptin in type 2 diabetes mellitus
William B. White, Richard E. Pratley, P. Fleck et al. · Diabetes Obesity and Metabolism · 2013 · 118 citations
Pharmacy, Pharmacology, Pharmacotherapy +16
The Effects of Psychotherapy, Nefazodone, and Their Combination on Subjective Assessment of Disturbed Sleep in Chronic Depression
Rachel Manber, A. John Rush, Michael E. Thase et al. · SLEEP · 2003 · 103 citations
Pharmacy, Pharmacotherapy, Psychiatry +17
Randomized, Placebo-Controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
Alan J. Gelenberg, Madhukar H. Trivedi, A. John Rush et al. · Biological Psychiatry · 2003 · 78 citations
Pharmacy, Pharmacotherapy, Psychiatry +14
Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience
John Marcinak, Melvin Munsaka, Paul B. Watkins et al. · Drug Safety · 2018 · 46 citations
Medicine, Internal Medicine, Pharmacology +15
Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants
Aziz Karim, Aziz Laurent, Melvin Munsaka et al. · The Journal of Clinical Pharmacology · 2009 · 34 citations
Medicine, Pharmacokinetics, Pharmacology +15
1–5 of 8